Serum lipids and urinary albumin excretion in non insulin-dependent diabetics

Mol Cell Biochem. 1992 Feb 12;109(2):197-200. doi: 10.1007/BF00229777.

Abstract

The increase of urinary albumin excretion has a predictive value for cardiovascular disease in insulin-dependent and non insulin-dependent diabetics. To study the relationship between urinary albumin excretion and serum lipids, 380 non insulin-dependent diabetics, 40 to 75 yr old, with urinary albumin excretion from 0 to 200 mg/l, and normal serum creatinine (less than 150 mumol/l), were surveyed. Urinary albumin excretion, was related positively to age (r2 = 0.014; p = 0.02), to systolic blood pressure (r2 = 0.073, p = 0.0001) and diastolic blood pressure (r2 = 0.052, p = 0.0001); a negative correlation existed with HDL-cholesterol (r2 = 0.043, p = 0.0001) and Apoprotein A1 (r2 = 0.044, p = 0.0001). A stepwise regression analysis was performed and resulted in three independently contributing variables related to urinary albumin excretion: First systolic blood pressure (F = 36), second Apoprotein A1 (F 24), third hemoglobin A1C (F = 6). The presence of hypertension or insulin therapy did not modify these findings. In conclusion, serum lipid seems an important determinant of urinary albumin excretion in non insulin-dependent diabetics.

MeSH terms

  • Adult
  • Aged
  • Albuminuria / etiology
  • Albuminuria / physiopathology
  • Albuminuria / urine*
  • Apolipoprotein A-I / analysis
  • Blood Pressure
  • Cardiovascular Diseases / epidemiology
  • Cardiovascular Diseases / etiology
  • Cholesterol, HDL / blood
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / drug therapy
  • Diabetes Mellitus, Type 2 / metabolism*
  • Diabetes Mellitus, Type 2 / physiopathology
  • Diabetic Nephropathies / etiology
  • Diabetic Nephropathies / physiopathology
  • Diabetic Nephropathies / urine*
  • Female
  • Humans
  • Hypertension / complications
  • Hypoglycemic Agents / therapeutic use
  • Insulin / therapeutic use
  • Lipids / blood*
  • Male
  • Middle Aged
  • Prevalence
  • Prognosis
  • Regression Analysis

Substances

  • Apolipoprotein A-I
  • Cholesterol, HDL
  • Hypoglycemic Agents
  • Insulin
  • Lipids